Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey

This publication has 24 references indexed in Scilit:

• Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders
  Transfusion, 2003
• The use of recombinant factor VIIa in children with inherited platelet function disorders
  British Journal of Haematology, 2003
• Recombinant factor VIIa enhances deposition of platelets with congenital or acquired αIIbβ3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor–independent thrombin generation
  Blood, 2003
• Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia
  Blood Coagulation & Fibrinolysis, 2003
• Use of Recombinant Factor VIIa for Bleeding in Children with Glanzmann Thrombasthenia
  Pediatric Hematology and Oncology, 2003
• Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti‐glycoprotein IIb–IIIa antibodies
  British Journal of Haematology, 2002
• Recombinant Activated Factor VII (rFVIIa): Characterization, Manufacturing, and Clinical Development
  Seminars in Thrombosis and Hemostasis, 2001
• Unique Pathway of Thrombin-induced Platelet Aggregation Mediated by Glycoprotein Ib
  Journal of Biological Chemistry, 2001
• Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".
  Journal of Clinical Investigation, 1996
• Pregnancy and Parturition in a Patient with Severe Glanzmann's Thrombasthenia
  Scandinavian Journal of Haematology, 1981